Treatment of alopecia areata (AA) remains challenging despite the advancement in all these years. Excimer phototherapy has been claimed to offer a practical alternative therapeutic option without significant risks. It is considered a “super-narrowband” UVB light source that emits energy at 308 nm. Excimer laser treatment achieves a remarkable effect in T cell-mediated disorders; thus, it has been used successfully in patients with AA. Compared with narrowband UVB, the excimer laser can induce apoptosis in vitro, paralleled by improved clinical efficacy. Both excimer laser and lamp have a similar effect, but they differ in technology. In this chapter, an evaluation of the effectiveness of 308 nm monochromatic excimer phototherapy in AA treatment is clinically warranted. The evidence-based studies that adopted this option using both laser and light are discussed. In addition, the formulation of therapeutic protocol to study the outcome of excimer treatment on moderate-to-severe AA in adults and children is described.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.